Fight Aging! is dedicated to sharing news and insights aimed at eliminating age-related diseases through the advancement of medical interventions that target the mechanisms of aging. Thousands of interested subscribers receive weekly newsletters from Fight Aging! To subscribe or unsubscribe, please visit: https://www.fightaging.org/newsletter/.
Longevity Industry Consulting Services:
Reason, the founder of Fight Aging! and Repair Biotechnologies, offers strategic consulting services for investors, entrepreneurs, and individuals interested in the longevity industry. To learn more, visit: https://www.fightaging.org/services/.
Contents:
– Novel mTOR Inhibitors Viewed as a Safer Option by Conservative Investors:
A discussion on the investment potential of mTOR inhibitors in the longevity industry, highlighting their low-risk nature and modest patient benefit compared to other approaches.
– Hevolution Foundation Announces 20 million Impact Investment to Advance Promising Aging Therapies, Leading a 50 million Series A Extension in Aeovian Pharmaceuticals:
Details of Hevolution Foundation’s significant investment in research and development of selective mTORC1 inhibitors for aging-related diseases, showcasing their commitment to advancing safe and effective treatments in the healthspan sector.
– LyGenesis Commences Phase II Trial for Growth of Liver Organoids in Patient Lymph Nodes:
An update on LyGenesis’ groundbreaking approach to growing liver organoids from donor cells in patient lymph nodes, potentially revolutionizing treatment for liver failure and expanding the pool of available organs for transplantation.
– Intermittent Methionione Restriction may be an Improvement on Continuous Methionine Restriction:
Insights into the benefits of methionine restriction in triggering metabolic responses akin to fasting and calorie restriction, highlighting its potential as an effective anti-aging intervention.
Each topic is discussed in depth, providing valuable information on the latest developments in the field of longevity and age-related disease prevention. For more details and to read the full articles, visit the provided links.
« Back to Top »
